Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome

Samar M. Said, Mary E. Fidler, Anthony M. Valeri, Brooke McCann, Wade Fiedler, Lynn D. Cornell, Mariam P Alexander, Ahmed M. Alkhunaizi, Anne Sullivan, Carl H. Cramer, Marie C Hogan, Samih H. Nasr

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Introduction Alport syndrome (AS) is a genetic disorder characterized by progressive hematuric nephropathy with or without sensorineural hearing loss and ocular lesions. Previous studies on AS included mostly children. Methods To determine the prognostic value of loss of staining for collagen type IV alpha 5 (COL4A5) and its relationship with the ultrastructural glomerular basement membrane alterations, we performed direct immunofluorescence using a mixture of fluorescein isothiocyanate-conjugated and Texas-red conjugated antibodies against COL4A5 and COL4A2, respectively, on renal biopsies of 25 males with AS (including 16 who were diagnosed in adulthood). Results All patients showed normal positive staining of glomerular basement membranes and tubular basement membranes for COL4A2. Of the 25 patients, 10 (40%) patients showed loss of staining for COL4A5 (including 89% of children and 13% of adults) and the remaining 15 (60%) had intact staining for COL4A5. Compared with patients with intact staining for COL4A5, those with loss of staining had more prominent ultrastructural glomerular basement membrane alterations and were younger at the time of biopsy. By Kaplan-Meier survival analysis and Cox regression analysis, loss of staining for COL4A5 predicted earlier progression to overt proteinuria and stage 2 chronic kidney disease or worse. By multivariate Cox regression analysis, loss of staining for COL4A5 was an independent predictor of the development of overt proteinuria and stage 2 chronic kidney disease or worse. Discussion Thus, the COL4A5 expression pattern has an important prognostic value and it correlates with the severity of ultrastructural glomerular basement membrane alterations in males with AS. Loss of COL4A5 staining is uncommon in patients with AS diagnosed in their adulthood.

Original languageEnglish (US)
Pages (from-to)44-52
Number of pages9
JournalKidney International Reports
Volume2
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Hereditary Nephritis
Negative Staining
Staining and Labeling
Glomerular Basement Membrane
Chronic Renal Insufficiency
Proteinuria
Regression Analysis
Direct Fluorescent Antibody Technique
Inborn Genetic Diseases
Collagen Type IV
Sensorineural Hearing Loss
Kaplan-Meier Estimate
Survival Analysis
Fluorescein
Basement Membrane
Kidney
Biopsy

Keywords

  • Alport syndrome
  • collagen chains staining
  • electron microscopy
  • hereditary nephritis
  • renal biopsy

ASJC Scopus subject areas

  • Nephrology

Cite this

Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome. / Said, Samar M.; Fidler, Mary E.; Valeri, Anthony M.; McCann, Brooke; Fiedler, Wade; Cornell, Lynn D.; Alexander, Mariam P; Alkhunaizi, Ahmed M.; Sullivan, Anne; Cramer, Carl H.; Hogan, Marie C; Nasr, Samih H.

In: Kidney International Reports, Vol. 2, No. 1, 01.01.2017, p. 44-52.

Research output: Contribution to journalArticle

Said, SM, Fidler, ME, Valeri, AM, McCann, B, Fiedler, W, Cornell, LD, Alexander, MP, Alkhunaizi, AM, Sullivan, A, Cramer, CH, Hogan, MC & Nasr, SH 2017, 'Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome', Kidney International Reports, vol. 2, no. 1, pp. 44-52. https://doi.org/10.1016/j.ekir.2016.09.056
Said, Samar M. ; Fidler, Mary E. ; Valeri, Anthony M. ; McCann, Brooke ; Fiedler, Wade ; Cornell, Lynn D. ; Alexander, Mariam P ; Alkhunaizi, Ahmed M. ; Sullivan, Anne ; Cramer, Carl H. ; Hogan, Marie C ; Nasr, Samih H. / Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome. In: Kidney International Reports. 2017 ; Vol. 2, No. 1. pp. 44-52.
@article{00e81953ee724fcc8962691579163059,
title = "Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome",
abstract = "Introduction Alport syndrome (AS) is a genetic disorder characterized by progressive hematuric nephropathy with or without sensorineural hearing loss and ocular lesions. Previous studies on AS included mostly children. Methods To determine the prognostic value of loss of staining for collagen type IV alpha 5 (COL4A5) and its relationship with the ultrastructural glomerular basement membrane alterations, we performed direct immunofluorescence using a mixture of fluorescein isothiocyanate-conjugated and Texas-red conjugated antibodies against COL4A5 and COL4A2, respectively, on renal biopsies of 25 males with AS (including 16 who were diagnosed in adulthood). Results All patients showed normal positive staining of glomerular basement membranes and tubular basement membranes for COL4A2. Of the 25 patients, 10 (40{\%}) patients showed loss of staining for COL4A5 (including 89{\%} of children and 13{\%} of adults) and the remaining 15 (60{\%}) had intact staining for COL4A5. Compared with patients with intact staining for COL4A5, those with loss of staining had more prominent ultrastructural glomerular basement membrane alterations and were younger at the time of biopsy. By Kaplan-Meier survival analysis and Cox regression analysis, loss of staining for COL4A5 predicted earlier progression to overt proteinuria and stage 2 chronic kidney disease or worse. By multivariate Cox regression analysis, loss of staining for COL4A5 was an independent predictor of the development of overt proteinuria and stage 2 chronic kidney disease or worse. Discussion Thus, the COL4A5 expression pattern has an important prognostic value and it correlates with the severity of ultrastructural glomerular basement membrane alterations in males with AS. Loss of COL4A5 staining is uncommon in patients with AS diagnosed in their adulthood.",
keywords = "Alport syndrome, collagen chains staining, electron microscopy, hereditary nephritis, renal biopsy",
author = "Said, {Samar M.} and Fidler, {Mary E.} and Valeri, {Anthony M.} and Brooke McCann and Wade Fiedler and Cornell, {Lynn D.} and Alexander, {Mariam P} and Alkhunaizi, {Ahmed M.} and Anne Sullivan and Cramer, {Carl H.} and Hogan, {Marie C} and Nasr, {Samih H.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.ekir.2016.09.056",
language = "English (US)",
volume = "2",
pages = "44--52",
journal = "Kidney International Reports",
issn = "2468-0249",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Negative Staining for COL4A5 Correlates With Worse Prognosis and More Severe Ultrastructural Alterations in Males With Alport Syndrome

AU - Said, Samar M.

AU - Fidler, Mary E.

AU - Valeri, Anthony M.

AU - McCann, Brooke

AU - Fiedler, Wade

AU - Cornell, Lynn D.

AU - Alexander, Mariam P

AU - Alkhunaizi, Ahmed M.

AU - Sullivan, Anne

AU - Cramer, Carl H.

AU - Hogan, Marie C

AU - Nasr, Samih H.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Introduction Alport syndrome (AS) is a genetic disorder characterized by progressive hematuric nephropathy with or without sensorineural hearing loss and ocular lesions. Previous studies on AS included mostly children. Methods To determine the prognostic value of loss of staining for collagen type IV alpha 5 (COL4A5) and its relationship with the ultrastructural glomerular basement membrane alterations, we performed direct immunofluorescence using a mixture of fluorescein isothiocyanate-conjugated and Texas-red conjugated antibodies against COL4A5 and COL4A2, respectively, on renal biopsies of 25 males with AS (including 16 who were diagnosed in adulthood). Results All patients showed normal positive staining of glomerular basement membranes and tubular basement membranes for COL4A2. Of the 25 patients, 10 (40%) patients showed loss of staining for COL4A5 (including 89% of children and 13% of adults) and the remaining 15 (60%) had intact staining for COL4A5. Compared with patients with intact staining for COL4A5, those with loss of staining had more prominent ultrastructural glomerular basement membrane alterations and were younger at the time of biopsy. By Kaplan-Meier survival analysis and Cox regression analysis, loss of staining for COL4A5 predicted earlier progression to overt proteinuria and stage 2 chronic kidney disease or worse. By multivariate Cox regression analysis, loss of staining for COL4A5 was an independent predictor of the development of overt proteinuria and stage 2 chronic kidney disease or worse. Discussion Thus, the COL4A5 expression pattern has an important prognostic value and it correlates with the severity of ultrastructural glomerular basement membrane alterations in males with AS. Loss of COL4A5 staining is uncommon in patients with AS diagnosed in their adulthood.

AB - Introduction Alport syndrome (AS) is a genetic disorder characterized by progressive hematuric nephropathy with or without sensorineural hearing loss and ocular lesions. Previous studies on AS included mostly children. Methods To determine the prognostic value of loss of staining for collagen type IV alpha 5 (COL4A5) and its relationship with the ultrastructural glomerular basement membrane alterations, we performed direct immunofluorescence using a mixture of fluorescein isothiocyanate-conjugated and Texas-red conjugated antibodies against COL4A5 and COL4A2, respectively, on renal biopsies of 25 males with AS (including 16 who were diagnosed in adulthood). Results All patients showed normal positive staining of glomerular basement membranes and tubular basement membranes for COL4A2. Of the 25 patients, 10 (40%) patients showed loss of staining for COL4A5 (including 89% of children and 13% of adults) and the remaining 15 (60%) had intact staining for COL4A5. Compared with patients with intact staining for COL4A5, those with loss of staining had more prominent ultrastructural glomerular basement membrane alterations and were younger at the time of biopsy. By Kaplan-Meier survival analysis and Cox regression analysis, loss of staining for COL4A5 predicted earlier progression to overt proteinuria and stage 2 chronic kidney disease or worse. By multivariate Cox regression analysis, loss of staining for COL4A5 was an independent predictor of the development of overt proteinuria and stage 2 chronic kidney disease or worse. Discussion Thus, the COL4A5 expression pattern has an important prognostic value and it correlates with the severity of ultrastructural glomerular basement membrane alterations in males with AS. Loss of COL4A5 staining is uncommon in patients with AS diagnosed in their adulthood.

KW - Alport syndrome

KW - collagen chains staining

KW - electron microscopy

KW - hereditary nephritis

KW - renal biopsy

UR - http://www.scopus.com/inward/record.url?scp=85016389173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016389173&partnerID=8YFLogxK

U2 - 10.1016/j.ekir.2016.09.056

DO - 10.1016/j.ekir.2016.09.056

M3 - Article

VL - 2

SP - 44

EP - 52

JO - Kidney International Reports

JF - Kidney International Reports

SN - 2468-0249

IS - 1

ER -